133 related articles for article (PubMed ID: 35489731)
1. The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Hashimoto I; Kano K; Hara K; Cho H; Segami K; Machida D; Nakazono M; Oshima T; Yukawa N; Rino Y
Anticancer Res; 2022 May; 42(5):2711-2717. PubMed ID: 35489731
[TBL] [Abstract][Full Text] [Related]
2. The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Onodera A; Morita J; Hashimoto I; Ishiguro T; Endo K; Cho H; Onuma S; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1916-1922. PubMed ID: 35738628
[TBL] [Abstract][Full Text] [Related]
3. Clinical Impact of Platelet-to-albumin Ratio on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Morita J; Hashimoto I; Ishiguro T; Onodera A; Cho H; Endo K; Onuma S; Kano K; Hara K; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1896-1902. PubMed ID: 35738593
[TBL] [Abstract][Full Text] [Related]
4. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Ju M; Machida D; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Hara K; Segami K; Hashimoto I; Nagasawa S; Nakazono M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(3):1424-1431. PubMed ID: 35478112
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Curatively Resected Gastric Cancer.
Ju M; Aoyama T; Fukuda M; Ishiguro T; Kano K; Kazama K; Sawazaki S; Tamagawa H; Yukawa N; Rino Y
Cancer Diagn Progn; 2022; 2(6):627-633. PubMed ID: 36340444
[TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation score as a preoperative prognostic factor for patients with pT2-T4 resectable gastric cancer: a retrospective study.
Matsumoto T; Ohki S; Kaneta A; Matsuishi A; Maruyama Y; Yamada L; Tada T; Hanayama H; Watanabe Y; Hayase S; Okayama H; Sakamoto W; Momma T; Saze Z; Kono K
BMC Surg; 2023 Jan; 23(1):8. PubMed ID: 36635689
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma.
Han L; Song Q; Jia Y; Chen X; Wang C; Chen P; Min R; Cheng Y
Tumour Biol; 2016 Mar; 37(3):3081-90. PubMed ID: 26423404
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Kato A; Maezawa Y; Hashimoto I; Hara K; Komori K; Kawahara S; Numata M; Kazama K; Sawazaki S; Kamiya N; Yoshizawa S; Otani K; Tamagawa A; Cho H; Tamagawa H; Oshima T; Yukawa N; Saito A; Rino Y
Anticancer Res; 2024 Jan; 44(1):339-346. PubMed ID: 38159996
[TBL] [Abstract][Full Text] [Related]
10. A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer.
Suzuki T; Ishibashi Y; Tsujimoto H; Nomura S; Kouzu K; Itazaki Y; Sugihara T; Harada M; Ito N; Sugasawa H; Kishi Y; Ueno H
In Vivo; 2020; 34(6):3705-3711. PubMed ID: 33144487
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Prediction Value of Systemic Inflammation Score and the Development of a Nomogram for Patients With Surgically Treated Breast Cancer.
Huang ZZ; Hua X; Song CG; Xia W; Bi XW; Yuan ZY; He ZY; Huang JJ
Front Oncol; 2020; 10():563731. PubMed ID: 33194636
[No Abstract] [Full Text] [Related]
12. Prognostic Value of Systemic Inflammation Score for Esophageal Cancer Patients Undergoing Surgery: A Systematic Review and Meta-Analysis.
Shi L; Wang X; Yan C
J Invest Surg; 2023 Dec; 36(1):2197058. PubMed ID: 37068785
[TBL] [Abstract][Full Text] [Related]
13. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With Pancreatic Ductal Adenocarcinoma.
Iguchi T; Iseda N; Hirose K; Itoh S; Harada N; Ninomiya M; Sugimachi K; Honboh T; Maeda T; Sadanaga N; Matsuura H
Am Surg; 2023 Jun; 89(6):2213-2219. PubMed ID: 35392670
[TBL] [Abstract][Full Text] [Related]
15. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of esophagectomy for esophageal cancer in elderly patients: a case-control study.
Tsuchiya N; Kunisaki C; Sato S; Tanaka Y; Sato K; Watanabe J; Takeda K; Kosaka T; Akiyama H; Endo I
Langenbecks Arch Surg; 2021 Dec; 406(8):2687-2697. PubMed ID: 34258676
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma.
Inokuchi S; Itoh S; Yoshizumi T; Morinaga A; Toshima T; Takeishi K; Nagao Y; Harada N; Ikegami T; Shimokawa M; Mori M
Langenbecks Arch Surg; 2021 May; 406(3):773-779. PubMed ID: 33595705
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Advanced Gastric Cancer.
Hara K; Aoyama T; Yamada T; Nakazono M; Nagasawa S; Shimoda Y; Kumazu Y; Numata M; Hayashi T; Tamagawa H; Shiozawa M; Morinaga S; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
Anticancer Res; 2020 Mar; 40(3):1503-1512. PubMed ID: 32132050
[TBL] [Abstract][Full Text] [Related]
19. Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal Cancer.
Tamagawa H; Tamagawa A; Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kato A; Kamiya N; Otani K; Numata M; Kazama K; Morita J; Tanabe M; Onuma S; Cho H; Sawazaki S; Ohshima T; Yukawa N; Mitsudo K; Saito A; Rino Y
In Vivo; 2023; 37(5):2253-2259. PubMed ID: 37652503
[TBL] [Abstract][Full Text] [Related]
20. The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.
Yukawa N; Aoyama T; Tamagawa H; Tamagawa A; Atsumi Y; Kawahara S; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Masuda M; Rino Y
In Vivo; 2020; 34(4):2087-2093. PubMed ID: 32606187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
